Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram



Status:Completed
Conditions:Infectious Disease, Women's Studies
Therapuetic Areas:Immunology / Infectious Diseases, Reproductive
Healthy:No
Age Range:18 - 60
Updated:3/15/2019
Start Date:January 2007
End Date:December 2010

Use our guide to learn which trials are right for you!

Chagas disease is endemic to the Americas, infecting between 16-18 million individuals. In
immigrant populations in the United States from endemic areas, it is estimated up to 4.9% may
be asymptomatic carriers of Trypanosoma cruzi, the organism which causes Chagas disease.
Between 10-20% of these patients progress to development of end-stage cardiomyopathy with a
high associated morbidity. Following acute disease, patients enter into an indeterminate
phase which can last 10-20 years. The earliest sign of cardiac involvement usually is
electrocardiogram abnormalities. The most common abnormality is right bundle branch block
(RBBB), followed by left anterior fascicular block (LAFB), and left bundle branch block
(LBBB). Recent studies have shown that treatment of patients at this stage with
antiparasitics may delay the progression of overt cardiomyopathy.

At the University of California, Los Angeles, there is a large population of immigrant
patients from countries endemic to Chagas disease. The researchers propose that screening
patients with conduction abnormalities on electrocardiogram may be a potentially useful
method to identify patients with early cardiac manifestations of Chagas disease. The
researchers hope to enroll approximately 300 individuals with RBBB, LAFB or LBBB on
electrocardiogram to determine the incidence of Chagas disease in this patient population.


Inclusion Criteria:

- One of the following EKG abnormalities:

- Complete or incomplete right bundle branch block (RBBB)

- Left anterior fascicular block (LAFB)

- Left bundle branch block (LBBB)

- Residence at any point in past in an endemic area (any country in Central or South
America or Mexico) for at least 12 months.

- Age >18 and <60.

Exclusion Criteria:

- Ejection fraction <40%

- Symptomatic heart failure

- Documented coronary artery disease
We found this trial at
1
site
Sylmar, California 91342
?
mi
from
Sylmar, CA
Click here to add this to my saved trials